reports
- GlobalData Healthcare Department
Crossject SA (ALCJ) - Financial Analysis Review
Crossject SA (ALCJ) - Financial Analysis Review Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by combining drug molecules with zeneo. Crossject’s zeneo is the exclusive needle-free injection system that can deliver drugs intradermally, subcutan...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.